GMED Globus Medical, Inc.
Healthcare$85.10+0.34%ClosedMarket Cap: $11.48B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$110.29
Target (Median)
$112.00
Target Range
$100.00 - $117.00
Upside from current price: 29.6%
Rating Distribution
4 Strong Buy6 Buy4 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-08 | RBC Capital | maintain | Outperform | Outperform |
| 2026-05-08 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-05-08 | Needham | maintain | Buy | Buy |
| 2026-02-26 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-02-25 | Needham | maintain | Buy | Buy |
| 2026-02-25 | Barclays | maintain | Overweight | Overweight |
| 2026-01-09 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-01-08 | Piper Sandler | maintain | Overweight | Overweight |
| 2025-12-17 | RBC Capital | maintain | Outperform | Outperform |
| 2025-12-02 | Morgan Stanley | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $5.14 | $3.41B | 8 |
| Sun Dec 31 | $5.70 | $3.64B | 4 |
| Mon Dec 31 | $6.23 | $3.92B | 2 |
| Tue Dec 31 | $6.78 | $4.16B | 2 |